- ►shouxi.net K Dungan, JB Buse - Clinical diabetes, 2005 - Am Diabetes Assoc GLP-1 secretion is decreased in type 2 diabetes, thus making it a logical target
for novel treatments of type 2 diabetes. 7 In clinical trials, GLP-1 effects are
evident regardless of the duration or severity of diabetes. 8 Thus, ... Cited by 23 - Related articles - All 5 versions
J McQueen - American Journal of Health-System Pharmacy, 2005 - ASHP Purpose. The pharmacology, pharmacoki- netics, clinical efficacy, adverse
effects, and dosage and administration of pramlintide are reviewed. Summary.
Pramlintide, a synthetic ana- logue of the human hormone amylin, is the ... Cited by 12 - Related articles - BL Direct - All 6 versions
[CITATION] Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia, report of WHO …